STAAR Surgical Announces U.S. FDA Approval of EVO Visian® Implantable Collamer® Lenses

LAKE FOREST, Calif.--(BUSINESS WIRE)--Mar 28, 2022--

Related Keywords

California ,United States ,Aliso Viejo ,Monrovia ,Montserrado ,Liberia ,Switzerland ,Nidau ,Switzerland General ,Lake Forest ,American ,Caren Mason ,Scottd Barnes ,Jen Jones ,Brian Moore ,I Diadenosine Nucleotid ,Exchange Commission ,American Society Of Cataract ,Company Annual Report On Form ,Surgical Company ,Corporate Development ,Drug Administration ,Implantable Collamer ,Life Without ,Business Wire ,Life Without Hesitation ,Animated Procedure ,Visual Freedom ,Chief Medical Officer ,High Myopia ,Temporal Trends ,Refractive Surgery Report ,Implantable Collamer Lens ,Clinical Ophthalmology ,Lopez De La Rosa ,Visian Phakic Implantable Collamer Lens ,Visual Performance ,Nucleotid Measurements ,Dry Eye Score ,Patients After ,American Society ,Refractive Surgery ,Annual Report ,Safety Information ,Media Relations ,Covid19 ,Coronavirus ,Covid 19 ,New Products And Services ,Product Approvals ,Laser Eye Surgery ,Eye Health ,Iagnosis And Treatment ,Surgical Procedures ,Ung Disease ,Iseases And Conditions ,Infectious Diseases ,Health ,Business ,Corporate News ,Products And Services ,Product Safety ,Ovid 19 Pandemic ,